Application 207467
- Type
- ANDA
- Sponsor
- TECH ORGANIZED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEVIRAPINE | NEVIRAPINE | TABLET, EXTENDED RELEASE;ORAL | 100MG | No | No |
| 002 | NEVIRAPINE | NEVIRAPINE | TABLET, EXTENDED RELEASE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207467-001 | NEVIRAPINE | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | ||
| A207467-002 | NEVIRAPINE | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207467-001 | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207467-002 | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 2017-07-31 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nevirapine | NEVIRAPINE | Mylan Pharmaceuticals Inc. | c6e93829-7024-48f6-8023-da6ff27dfc0a | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | Nevirapine NEVIRAPINE |
| NEVIRAPINE | NEVIRAPINE | Micro Labs Limited | fbd628db-4076-4fe0-8323-9cc33ae92e42 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Mylan Pharmaceuticals Inc. | 690da74b-2481-47fc-93ae-8340e0caf0a4 | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | Nevirapine NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Aurobindo Pharma Limited | 8dfe86aa-ea5d-48d2-94a8-1a5506055d70 | 2024-09-04 | Boxed warning, Warnings, Adverse reactions | Nevirapine NEVIRAPINE |
| NEVIRAPINE | NEVIRAPINE | Macleods Pharmaceuticals Limited | 2620b114-f53f-44f1-8708-697e86343090 | 2024-08-14 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Aurobindo Pharma Limited | 5f6c3eed-2a5d-46ed-9a7c-59715f338a15 | 2024-05-20 | Boxed warning, Warnings, Adverse reactions | Nevirapine NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Camber Pharmaceuticals, Inc. | 61409678-d2f6-42cd-b03d-b26b11b39641 | 2022-08-03 | Boxed warning, Warnings, Adverse reactions | Nevirapine NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Amneal Pharmaceuticals LLC | 4f065674-4719-4c79-ba0d-549040d77f17 | 2012-08-30 | Boxed warning, Warnings, Adverse reactions | Nevirapine NEVIRAPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.